Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-26-082831
Filing Date
2026-02-27
Accepted
2026-02-27 16:30:32
Documents
1
Period of Report
2026-02-26

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 6447
  Complete submission text file 0001193125-26-082831.txt   8063
Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON United Kingdom W1G 0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON United Kingdom W1G 0QF 4403330237300
Mereo BioPharma Group plc (Issuer) CIK: 0001719714 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 5505 ENDEAVOR LANE MADISON WI 53719
Business Address
Jacquet Pierre (Reporting) CIK: 0001783451 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38452 | Film No.: 26700585